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ABSTRACT
Objectives: To evaluate the presence of upper urinary tract 
deterioration (UUTD) and accompanying pathologies in children 
treated with the diagnosis of non-neurogenic bladder-sphincter 
dysfunction (NNBSD). 
Patients  and Methods: We retrospectively reviewed the 
medical records of 316 consecutive patients with NNBSD 
who were treated.  All cohort were grouped into two: Group I 
(Treatment success; n=284), Group II (Treatment failure with any 
form of occult spinal pathology; n=32). Thirty-four children with 
treatment-failure and normal magnetic resonance imaging (MRI) 
findings were excluded. Groups were compared for pre- and post-
treatment pediatric lower urinary tract symptom score (PLUTSS), 
presence of UUTD and urodynamic findings. 
Results: The mean PLUTSS was significantly less in Group I 
compared with Group II at pre-treatment and 3 months thereafter 
the initial treatment (12.20 ± 5.90 and 5.20 ± 4.90 vs 20.3 ± 2.14 
and 18 ± 3.4, respectively p<0.01). The mean cystometric capacities 
and detrusor leak point pressure (DLPP) of Group II prior to initial 
treatment and  after 6 months of the untethering surgery were found 
to be 194, 267 mL and 28, 12cm H2O, respectively (p<0.05). 
Presence of UUTD was significantly correlated with DLPP >20 cm 
H2O and presence of vesicoureteral reflux (VUR). 
Conclusion: UUTD in NNBSD is more common in children 
with occult spinal pathology, than in those without.
Keywords: Non-neuropathic bladder sphincter dysfunction, Upper 
urinary tract deterioration, Symptom score
ÖZ
Amaç: Nörojenik olmayan mesane–sfinkter fonksiyon bozukluğu 
(NOMSFB) tanısıyla tedavi edilen çocuklarda üst üriner sistem 
hasarı (ÜÜSH) ve eşlik eden patolojilerin araştırılmasıdır. 
Hastalar ve Yöntemler: NOMSFB nedeniyle kliniğimizde 
tedavi edilen 316 çocuğun tıbbi kayıtları retrospektif olarak 
incelendi. Çocuklar,  tedavi yanıtına ve magnetic resonans 
görüntüleme  (MRG) bulgularına göre iki gruba ayrıldılar: Grup 
I (Tedaviye yanıt verenler; n=284) ile Grup II (Tedaviye dirençli 
olup,  lomber MRG’sinde gizli spinal disrafizm bulgusu olanlar; 
n=32). Tedaviye dirençli olup lomber MRG’sinde patoloji 
saptanmayan 34 çocuk çalışma dışı bırakıldı. Gruplar tedavi öncesi 
ve sonrası semptom skoru (SS), ÜÜSH ile ürodinami bulguları 
açısından karşılaştırıldı. 
Bulgular: Tedavi öncesi dönemde ve tedavi başladıktan üç 
ay sonra, Grup I’in ortalama SS’si Grup II’ye göre anlamlı olarak 
düşük saptandı (sırasıyla 12,20 ± 5,90 ve 5,20 ± 4,90 karşın 20,3 
± 2,14 ve 18 ± 3,4; p<0.01). Grup II’nin başlangıç tedavisi öncesi 
ortalama sistometrik kapasitesi ve detrüsör kaçırma anı basıncı 
(DKAB) sırasıyla 194 ml ve 28 cm H2O olarak saptandı. Grup 
II’nin gergin omurilik onarımını takip eden altıncı ayda ortalama 
sistometrik kapasite ve ortalama DKAB sırasıyla 267 ml ve 12 
cmH2O olarak saptandı. ÜÜSH varlığı ile DKAB’ın 20 cmH2O 
üzeri olması ve vezikoüreteral reflü varlığı arasında anlamlı ilişki 
bulundu. 
Sonuç: NOMSFB’da ÜÜSH,  gizli spinal disrafizm varlığında 
daha sık görülür.
Anahtar kelimeler: Nörojenik olmayan mesane-sfinkter fonksiyon 
bozukluğu, Üst üriner sistem hasarı, Semptom skoru
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Introduction
Non-neurogenic bladder-sphincter dysfunction (NNBSD) 
is a frequently seen pathology in daily clinical practice of 
pediatric urology. Functional urinary incontinence and upper 
urinary tract deterioration (UUTD) are the most important 
complications of untreated NNBSD [1-4]. There seems 
to be a strong association between NNBSD and recurrent 
urinary tract infection (UTI) with or without accompanying 
vesicoureteral reflux (VUR) [2-4]. Treatment of NNBSD is 
essential in the management of recurrent UTI and VUR, as 
this prevents kidney damage [5, 6].
Dysfunctional voiding (DV), overactive bladder (OAB), 
and underactive bladder (UAB) are the main clinical outcomes 
of NNBSD [3]. Children with NNBSD who fail to respond 
to initial treatment should undergo a series of clinical study 
including urodynamics and lumbosacral magnetic resonance 
imaging (MRI) for the assessment of any occult spinal 
pathology [6, 7]. Afshar et al., reported that in a population 
of 73 NNBSD patients, 3 of 35 (8.6%) that failed in medical 
management had occult pathology [8]. Spinal dysraphism 
occurs in two forms: an open form named spina bifida 
aperta, and a closed form named spina bifida occulta. Either 
form of spinal deformity may feature as a progressive form 
of neurological deterioration called tethered cord syndrome 
which will finally need a neurosurgical intervention. MRI 
can be used to differentiate such neurologic abnormalities in 
patients with spinal dysraphism [9].
Generally UUTD with lower urinary tract dysfunction 
(LUTD) is related to tethered cord, thus one can expect 
similar predisposing factors for UUTD like in NNBSD [7]. 
Such factors include UTI, ongoing VUR, a high bladder 
filling and/or voiding pressure, and discoordinated voiding.
The aim of the current study was to evaluate the presence 
of UUTD and the related conditions in patients who have 
received an optimal treatment for NNBSD and yet were 
identified as having occult spinal pathology, both during 
treatment and during the early follow up period.
Patients and Method
Study Population
The study involved children who were diagnosed with 
NNBSD after admission to Marmara University, School 
of Medicine, Pediatric Urology Outpatient Clinic between 
November 2010 and June 2015. All cohort had one or more 
of the following symptoms: daytime and/or nighttime urinary 
incontinence, holding maneuvers, perceived incomplete 
emptying, urinary urgency, post-micturition dribble, weak 
stream, urinary hesitancy, intermittency, increased urinary 
frequency and UTI. Medical records of each patient were 
retrospectively reviewed. Categories of patients with 
NNBSD were identified (methods detailed below) and 
respective management protocols were applied. Children 
who responded to treatment for NNBSD were grouped as 
Group I. Those who did not respond to treatment underwent 
further testing, and study group was established based on 
these findings.
Initial Diagnostics
Pediatric Lower Urinary Tract Symptom Score (PLUTSS): 
This score was originally developed and validated by Akbal 
et al. [10] (Fig. 1). This instrument has been widely used 
for clinical assessment of LUTD and has also been applied 
in research studies [11, 12]. Similar tools have also been 
reported to be used to assess children with lower urinary 
tract symptoms [13]. The PLUTSS was administered to 
each child and to his/her parents at initial clinical evaluation 
period (pre-treatment) and repeated in every 6 months 
periods thereafter (post-treatment). For each patient, the 
pre-treatment PLUTSS and the 6 months of post-treatment 
PLUTSS were used for the study.
Other Tests: Each patient underwent a combined 
uroflowmetry assessment with electromyography (EMG). 
Total bladder capacity was calculated by adding voided 
urine volume to measured post-voiding residual urine 
volume under ultrasonography (USG), and was expressed 
as a percentage of age-expected bladder capacity [14]. Each 
patient also completed a bladder diary for two days with the 
recommended entries of ICCS [14]. For the assessment of 
possible UUTD (i.e., hydronephrosis, parenchymal thinning, 
atrophy) each child underwent a routine imaging with USG. 
Those confirmed to have UTI and abnormal USG findings 
were further evaluated with voiding cystourethrography 
(VCUG). Grading of VUR was done according to the 
international classification [15, 16]. Children with VUR 
underwent a dimercaptosuccinic acid (DMSA) scan and 
the results of the scan were summarized as either normal or 
scarring for the present study [17].
Disease Categories and Management
Based on initial diagnostics, patients with NNBSD were 
categorized as OAB, DV, or UAB. Patients with OAB 
were treated with timed voiding regimens, medications of 
anticholinergics and/or antibiotics. Anticholinergic treatment 
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was done with oxybutynin in a dosage of 0.2 mg/kg via the 
enteral route. Patients with only nocturnal enuresis were 
advised to limit fluid intake in the evening and to urinate 
before going to bed. Those resistant to initial treatment for 
nocturnal symptoms were prescribed oral desmopressin 
(DDAVP) or alarm therapy, as recommended in pediatric 
urology guidelines [18].
Dysfunctional voiding was treated with timed voiding 
and positive reinforcement regimens, bowel regimens 
(including high daily fluid intake, a diet high in fiber, 
and stool softeners if necessary), biofeedback therapy, 
medications of alpha-blockers and/or antibiotics [19].
Underactive bladder was treated with clean intermittent 
catheterization and antibiotic prophylaxis. Bowel regimens 
were prescribed for patients with UAB who also had bowel 
problems.
Additional Diagnostic Testing in Cases of No Response
Children were treated for a minimum of 3 months before 
they were identified as non-responders. Based on pre- versus 
post-treatment PLUTSS results and discussion with patients 
and parents, “No response to treatment” was defined as 
any reduction of symptoms below 49% [14]. All of these 
children named as non-responders underwent urodynamic 
and radiographic assessments.
Urodynamic Evaluation: Standard filling cystometry 
(AYMED, Locum Wireless Urodynamic System, Turkey) 
was performed with the patient in supine position, using a 
6F double-lumen urethral cystometry catheter and filling 
rate was taken as 5% to 10% of predicted bladder capacity 
((age+1)x30) per minute [14]. According to a report from the 
Standardization Committee of the International Continence 
Society [20] and International Children’s Continence 
Society [21], we calculated the maximum detrusor pressure 
(P detmax, cm H2O), maximum cystometric capacity (MCC, 
ml), DLPP (cmH2O). Namely, The International Continence 
Society (ICS) defines the DLPP as the value of the lowest 
detrusor pressure at which leakage occurs in the absence 
of abdominal pressure rise. The DLPP was measured by 
marking the lowest pressure at the moment when the urine 
seeped out from the urethral meatus.
RadiographicEvaluation: A spinal MRI was performed 
and any finding of conus medullaris below the lower 
endplate of the L2 vertebra, lipoma or thickening of the 
filum terminale, and/or vertebral anomalies was considered 
as abnormal [9].
Statistical Analysis
Data were analyzed using the Statistical Package for the 
Social Sciences (SPSS v. 20, IBM Corporation, NY, USA). 
Findings for pre-treatment and six-months-post-treatment 
SS were compared using the unpaired Student’s t test. 
Relationships between presence of UUTD and urodynamic 
parameters were assessed using Pearson correlation analysis. 
P values <0.05 were considered significant.
Results
Of all 388 children a total of 34 children with NNBSD 
resistant to pharmacotherapy-urotherapy were excluded 
from the study, as they were candidates for other invasive 
treatment modalities (i.e., neuromodulation strategies, 
intradetrusor botulinium toxin A injection, or augmentation 
cystoplasty). Thirty-eight patients were lost to follow 
up. Group I patients (n=284) consisted of NNBSD and 
treated with standard modalities and follow-up. Group II 
patients (n=32) were children with NNBSD resistant to 
pharmacotherapy-urotherapy and were diagnosed as having 
any form of occult spinal pathology in further evaluation.
The mean follow-up time of the patients in the present 
study was 13.6 ± 7.8 months (range, 6-26 months). The 
mean ages of Groups I and II were not significantly different 
(8 ± 2.1 vs. 7 ± 2.3 years, respectively; p>0.05).
Of all the children in Group I, 97 had DV (34%), 170 
had OAB (60%) and 17 had UAB (6%). The mean PLUTSS 
results of the Group I patients at the pre-treatment period 
and 3 months thereafter was found to be 12.2 ± 5.9 and 5.2 
± 4.9, respectively.
Of all the children in Group II, 19 had DV (59%) and 13 
had OAB (41%). The mean PLUTSS results of the Group II 
patients at the pre-treatment period and 3 months thereafter 
was found to be 20.3 ± 2.1 and 18 ± 3.4, respectively. 
The mean PLUTSS at the first 6th month period following 
untethering surgery was found to be 12.2 ± 1.8. This final 
score was found to be significantly lower than the pre-
treatment PLUTSS (p<0.001), indicating an appropriate 
treatment for NNBSD.
Additional Testing - Urodynamic Findings
The mean cystometric capacities and mean DLPP of Group 
II prior to initial treatment was found to be 194 mL (min 
45 mL, max 302 mL) and 28 cm H2O (min 4 cm H2O, max 
58 cm H2O), respectively. The mean cystometric capacities 
and the mean DLPP of Group II patients after 6 months of 
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the untethering surgery was found to be 267 mL (min 145 
mL, max 335 mL) and 12 cm H2O (min 4 cm H2O, max 20 
cm H2O), respectively (p<0.05).
Upper Urinary Tract Deterioration
In the initial evaluation period of Group II, of all patients, 12 
(37.5%) were found to have an UUTD on DMSA scanning. 
During the follow-up period 10 (83.3%) of these 12 patients 
who had initial renal scars were seemed to be stabilized.
At initial assessment in Group II patients, 4 had VUR 
and 8 had a DLPP >20 cm H2O. Presence of an UUTD was 
significantly correlated with two occasions; either having a 
DLPP >20 cm H2O or having an accompanying VUR (Table II).
The proportion of patients with a history of recurrent 
UTI in Group II was significantly higher than that in Group I 
(76.5% vs. 31.2%, respectively; p<0.001) (data not shown).
Table I: The initial relation of upper urinary tract deterioration 
(UUTD) and detrusor leak point pressure (DLPP) in Group II 
patients prior to treatment is shown
UUTD
Absent (n)
UUTD
Present (n)
Total
(n)
DLPP > 20 cm H2O 8 8 16
DLPP < 20 cm H2O 14 2 16
Total 22 10 32
Table II: The significance of having a correlation with an upper 
urinary tract deterioration prior to treatment is given for some 
instances like a detrusor leak point pressure (DLPP) >20 cm H2O, 
presence of vesicoureteral reflux (VUR), and recurrent urinary 
tract infection (UTI). (r value of Pearson Correlation is given with 
its statistical significance)
r value p value
DLPP >20 cm H2O 0.459 <0.001
VUR 0.322 <0.01
Recurrent UTI 0.161 >0.05
Discussion
The findings of the present study, suggested a higher 
incidence of UUTD for patients with functional urinary 
incontinence that do not respond to treatment, if they 
had any occult spinal pathology. Of all the patients with 
functional urinary incontinence (n=388) only 8.8% (n=34) 
did not respond to our initial treatment regimen, and of 
these patients with treatment failure, almost all (n=32) 
were diagnosed as having tethered cord malformation. 
Considering the previous findings, it was advised to go for 
further radiologic imaging of spine by MRI in treatment-
failure of functional urinary incontinence, unless patients 
have normal urodynamic findings.
Pippi Salle et al., evaluated 32 consecutive children with 
complicated enuresis who were referred for neurosurgical 
evaluation [22]. They recorded normal spinal MRI findings 
in 21 patients (91.3%), including 1 with a tethered cord and 
lipoma associated with a complex skeletal abnormality, and 
1 with a nonprogressive, nonsurgical syrinx extending from 
T7 to T9 spinal levels. Only the case of lipoma required 
neurosurgical intervention. The authors concluded that MRI 
is of limited value in children with voiding dysfunction 
who have a normal neuro-orthopedic assessment, and that 
this modality should be reserved for those with associated 
neuro-orthopedic findings or complex skeletal deformity 
on plain x-ray(Pippi Salle, Capolicchio et al. 1998). In 
contrast, Arikan et al., investigated 81 children with voiding 
dysfunction and reported pathologic findings in 17 (38.6%) 
of 44 patients who had a normal neuro-orthopedic assessment 
[23]. They concluded that MRI of the lower spinal cord is 
a valuable tool for diagnosing occult spinal cord disorders, 
particularly in patients with the combination of voiding 
dysfunction refractory to conservative management and 
normal neurologic and orthopedic assessments.
Children who do not respond to behavioral or medical 
therapies for NNBSD should be considered candidates 
for invasive treatment modalities. Urinary incontinence is 
a very frequent problem encountered in pediatric urology 
outpatients. In our daily practice, most such children 
respond well to conservative methods such as timed voiding, 
behavioral modifications, biofeedback-coupled pelvic floor 
exercises, and anticholinergic agents. Schulman et al., found 
that conservative approaches were successful in 45% of 280 
children with urinary incontinence [24]. The mean age of 
those patients who responded at presentation was 8.5 years, 
and the mean follow-up time was 22 months. Another study 
by Curran et al., revealed a similar cure rate of 43% among 
30 patients with idiopathic detrusor overactivity. These 
authors described “complete resolution” in 87%; however, 
their definition of complete resolution included patients that 
were still on medication. Neither Schulman et al. nor Curran 
et al. were able to identify statistically significant clinical or 
urodynamic factors that predicted outcome [24, 25]. Weiner 
et al., reported a 60% treatment success rate after long-term 
follow up of children with daytime wetting [26].
Our study evaluated findings in children with tethered 
cord malformation. Such patients comprise a very small 
subset of many children who present with combination of 
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Figure 1: Pediatric Lower Urinary Tract Symptom Score (PLUTSS) [10]
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treatment-resistant functional voiding problems and UUTD. 
Most patients who are resistant to treatment and have 
abnormal urodynamic findings have some degree of spinal 
pathology and should undergo MRI. These children require 
evaluation by a pediatric neurosurgeon [22, 23].
According to the current study, the treatment resistant 
disease should be followed carefully after untethering surgery 
because of continuing symptoms. In case of tethered cord 
malformation, the correction is effective for normalization 
of bladder dynamics. Hsihe et al., demonstrated that in 
children with abnormal urodynamics due to tethered cord 
malformation, untethering surgery may improve or even 
provides normalization of voiding dysfunction [27].
Stone et al., reported that children who presented with 
daytime wetting, uninhibited bladder contractions, and 
detrusor-sphincter dyssynergia were most likely to remain 
symptomatic after first line treatment. They offer that these 
patients might be considered for more aggressive alternative 
therapies, after a period of medical management [28]. In our 
series most of the treatment resistant children had DV scores 
different from the treatment responders’ DV scores. In these 
cases main pathology was OAB.
The main factor for UUTD is having a reflux and 
high DLPP in our patient population. In our study, among 
patients who developed UUTD or patients with known but 
progressing UUTD, 4 had ongoing VUR and 8 had DLPP 
>20 cm H2O in Group II. Among these patients the mean 
grade of VUR before treatment was 2.7 (min 2 max 4) in 
Group II and after treatment was 2.3 (min 1 max 4). It is well 
known that management of VUR in presence of disturbed 
bladder dynamics is a tough challenge. Seki et al., showed 
that factors such as low bladder compliance, presence of DSD 
and high maximum urethral closing pressure contributed 
to the incidence of VUR and were directly correlated with 
UUT damage [29].
Those patients also face a high number of UTI attacks 
and these attacks might affect the treatment response. Bael et 
al., described that urodynamics added little to the treatment 
of patients with OAB symptoms in the European Bladder 
Dysfunction Study [30]. The pre-treatment urodynamic 
variable “detrusor overactivity throughout filling” correlated 
in only 33% of patients with the clinical diagnosis of urge 
syndrome. This finding implied that 67% of the children 
with complaints of frequency, urgency, daytime wetting and 
holding maneuvers did not have overactivity of the detrusor 
in the filling phase. After treatment the prevalence of detrusor 
overactivity still was 27% but two-thirds of these patients 
did not have detrusor overactivity before treatment, and in 
fact exhibited detrusor overactivity de novo [30]. It means 
that detrusor overactivity did not correlate with treatment 
outcome. Clearly, in urge syndrome urodynamic variables do 
not follow clinical symptoms. We assume that urgency and 
frequency are due to overactivity, and start specific treatment 
based on that assumption. The assumption may be right but 
urge syndrome and concomitant detrusor overactivity may 
just occur on provocation only, giving rise to complaints and 
the seeking of medical attention when coping mechanisms 
fail. Because of the above mentioned reasons, some of the 
patients in the Group II had symptoms after successful 
surgery and they needed additional treatment. The response 
period for those patients may last as we expected.
High detrusor leak point pressure is shown to be a risk 
factor for UUTD in children with spinal dysraphism. Values 
higher than 40 cm H2O are proven to be a major contribution 
to UUTD [31]. Even values between 20 and 40 cm H2O are 
shown to be more sensitive for predicting UUTD [32]. In our 
study, the DLPP of children above 20 cm H2O is related with 
UUTD which means determining the bladder urodynamic 
characteristics may be important in deciding emphasis of the 
treatment.
Thus, according to our results, treatment resistant children 
with abnormal spinal imaging have statistically more UUTD 
than children with treatment responders. More detailed 
randomized studies are needed to enlighten this situation.
Conclusion
Many normal children presenting with intractable voiding 
dysfunction fail to normalize with urotherapy and medical 
management. Those who are resistant to the treatment 
are candidates for UUTD. Those patients usually have 
concomitant VUR and high pressure bladder. In tethered 
cord patients, upper urinary tract damage is encountered 
more frequently than patients with treatment resistant cases.
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